Foresite Capital Management Iii, LLC Cyma Bay Therapeutics, Inc. Transaction History
Foresite Capital Management Iii, LLC
- $37.9 Million
- Q3 2022
A detailed history of Foresite Capital Management Iii, LLC transactions in Cyma Bay Therapeutics, Inc. stock. As of the latest transaction made, Foresite Capital Management Iii, LLC holds 1,641,804 shares of CBAY stock, worth $0. This represents 15.17% of its overall portfolio holdings.
Number of Shares
1,641,804
Previous 1,641,804
-0.0%
Holding current value
$0
Previous $4.84 Million
18.65%
% of portfolio
15.17%
Previous 17.57%
Shares
8 transactions
Others Institutions Holding CBAY
# of Institutions
7Shares Held
1.82MCall Options Held
0Put Options Held
0-
Abingworth LLP London, X0131KShares$00.27% of portfolio
-
Connacht Asset Management LP New York, NY12KShares$01.09% of portfolio
-
Ctc Capital Management, LLC10.7KShares$00.2% of portfolio
-
Pictet Asset Management Sa Geneva 73, V810.6KShares$00.0% of portfolio
-
First Republic Investment Management, Inc. San Francisco, CA10.6KShares$00.0% of portfolio
About CymaBay Therapeutics, Inc.
- Ticker CBAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 84,677,904
- Description
- CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...